BUZZ-U.S. STOCKS ON THE MOVE-Valeant, Array Biopharma, Northrop

Wed Dec 16, 2015 7:30am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index e-mini futures were higher on Wednesday ahead of a widely expected hike in interest rates by the Federal Reserve later in the day. Dow Jones industrial average futures were up 0.48 percent at 17,635, S&P 500 futures were up 0.42 percent at 2,054 and Nasdaq 100 futures were up 0.42 percent at 4,625.5.

** ARRAY BIOPHARMA INC, Tuesday close $3.83, +29.24 pct premarket

The company said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in an ongoing late-stage study.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Tuesday close $109.59, +2.75 pct premarket

The Canadian drugmaker cut its revenue and profit forecasts for 2015, but said it still expected double-digit percentage sales growth through higher volumes in 2016.

** NORTHROP GRUMMAN CORP, Tuesday close $187.84, +1.68 pct premarket

The company riding high after its selection to build the next U.S. long-range bomber, says it is investing heavily and hiring workers as part of a focused plan to unveil at least one "big, bold and ingenious" new technology each year.

** ASTRAZENECA PLC, Tuesday close $33.26, +0.81 pct premarket   Continued...